Skip to main content
. Author manuscript; available in PMC: 2015 Mar 1.
Published in final edited form as: J Rheumatol. 2014 Jan 15;41(3):509–515. doi: 10.3899/jrheum.130609

Table 4.

Minimal Clinically Important Difference (MCID) and Moderate Improvement thresholds in patients with knee symptoms

Improvement in score Mean (SD) Relative (%) improvement in score MDC90
ICOAP Pain (scale 0100)
Moderate Improvement (=“great deal better”) (N=12) −26.7 (±14.8) −60.5% 49.6
MCID Improvement (=“somewhat better”) (N=26) −18.5 (±22.0) −31.0% 46.6
ICOAP Constant Pain
Moderate Improvement (=“great deal better”) (N=12) −29.6 (±14.8) −68.3% 53.8
MCID Improvement (=“somewhat better”) (N=26) −18.7 (±24.4) −32.7% 49.6
ICOAP Intermittent Pain
Moderate Improvement (=“great deal better”) (N=12) −24.3 (±17.9) −54.3% 48.7
MCID Improvement (=“somewhat better”) (N=26) −18.4 (±25.4) −29.7% 50.8
KOOS-PS (scale 0100)
Moderate Improvement (=“great deal better”) (N=12) −15.0 (±16.4) −32.3% 35.5
MCID Improvement (=“somewhat better”) (N=26) −2.2 (±17.5) −4.0% 28.3
KOOS-QOL (scale 0100)
Moderate Improvement (=“great deal better”) (N=12) 15.6 (±18.8) 35.7% 39.0
MCID Improvement (=“somewhat better”) (N=25) 8.0 (±16.1) 25.7% 29.0

Relative (%) improvement in score was calculated as = 100* (followup score mean−baseline score mean)/baseline score mean